| Literature DB >> 16283947 |
Rolanda M Baars1, Clare I Atherton, Hendrik M Koopman, Monika Bullinger, Mick Power.
Abstract
BACKGROUND: The European DISABKIDS project aims to enhance the Health Related Quality of Life (HRQoL) of children and adolescents with chronic medical conditions and their families. We describe the development of the seven cross-nationally tested condition-specific modules of the European DISABKIDS HRQoL instrument in a population of children and adolescents. The condition-specific modules are intended for use in conjunction with the DISABKIDS chronic generic module.Entities:
Mesh:
Year: 2005 PMID: 16283947 PMCID: PMC1326227 DOI: 10.1186/1477-7525-3-70
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
Figure 1Modular design of the DISABKIDS* and KIDSCREEN† instrument.
Figure 2Work packages within the DISABKIDS project.
Number of items and participants (n = 360) in the pilot study for each condition-specific module
| Asthma | 32 | 132 | 37 |
| Juvenile idiopathic arthritis | 44 | 54 | 15 |
| Atopic dermatitis | 36 | 29 | 8 |
| Cerebral palsy | 26 | 21 | 6 |
| Cystic fibrosis | 38 | 28 | 8 |
| Diabetes mellitus | 28 | 59 | 16 |
| Epilepsy | 27 | 37 | 10 |
Domains, number of items (n) and the Cronbach's alpha (α) after the pilot analysis
| Asthma | Impact | 8 | .83 | Worry | 5 | .86 | . | . | . |
| Juvenile idiopathic arthritis | Limitation | 6 | .82 | Understanding | 6 | .75 | Frustration | 5 | .77 |
| Atopic dermatitis | Impact | 7 | .84 | Skin | 5 | .77 | Shame | 4 | .77 |
| Cerebral palsy | Limitation | 5 | .84 | Frustration | 7 | .81 | . | . | . |
| Cystic fibrosis | Impact | 6 | .77 | Treatment | 8 | .87 | . | . | . |
| Diabetes mellitus | Impact | 5 | .84 | Food | 5 | .76 | Injections | 5 | .82 |
| Epilepsy | Fear | 8 | .89 | Social | 6 | .77 | . | . | . |
Number of items and participants (n = 1152) in the field study for each condition-specific module
| Asthma | 15 | 405 | 35 |
| Juvenile idiopathic arthritis | 19 | 150 | 13 |
| Atopic dermatitis | 19 | 65 | 5 |
| Cerebral palsy | 16 | 43 | 4 |
| Cystic fibrosis | 14 | 91 | 8 |
| Diabetes mellitus | 15 | 207 | 18 |
| Epilepsy | 16 | 191 | 17 |
Domains, number of items (n) and Cronbach's alpha (α) after the field study analysis
| Asthma | Impact | 6 | .83 | Worry | 5 | .84 |
| Juvenile idiopathic arthritis | Impact | 9 | .87 | Understanding | 3 | .73 |
| Atopic dermatitis | Impact | 8 | .87 | Stigma | 4 | .71 |
| Cerebral palsy | Impact | 10 | .82 | Communication | 2* | .72 |
| Cystic fibrosis | Impact | 4 | .80 | Treatment | 6 | .85 |
| Diabetes mellitus | Impact | 6 | .83 | Treatment | 4 | .84 |
| Epilepsy | Impact | 5 | .90 | Social | 5 | .84 |
*With only two items this is the inter-item correlation.
The Cronbach's alpha (α) and number of participants (p) for the final two asthma-specific domains calculated for each country
| Austria | .77 | 30 | .80 | 30 |
| France | .84 | 36 | .77 | 34 |
| Germany | .91 | 38 | .88 | 41 |
| Greece | .72 | 29 | .61 | 38 |
| Netherlands | .81 | 122 | .84 | 127 |
| Scotland | .86 | 48 | .84 | 49 |
| Sweden | .85 | 72 | .86 | 73 |